Hypothesis

3 Matching Annotations

Feb 2026
www.biorxiv.org www.biorxiv.org

IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer

1
1. scibot 05 Feb 2026
  
  in Public
  
  RRID:AB_2563402
  
  DOI: 10.64898/2026.01.29.702661
  
  Resource: (BioLegend Cat# 362004 (also 362003), RRID:AB_2563402)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563402
  
  What is this?
  
  RRID:AB_2563402
Visit annotations in context

Tags

RRID:AB_2563402

Annotators

scibot

URL

biorxiv.org/content/10.64898/2026.01.29.702661v1
Feb 2024
www.sciencedirect.com www.sciencedirect.com

Clonal differences underlie variable responses to sequential and prolonged treatment

2
1. scibot 27 Feb 2024
  
  in Public
  
  RRID:AB_2563402
  
  DOI: 10.1016/j.cels.2024.01.011
  
  Resource: AB_2563402
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563402
  
  What is this?
  
  RRID:AB_2563402
2. scibot 27 Feb 2024
  
  in Public
  
  RRID:AB_2563402
  
  DOI: 10.1016/j.cels.2024.01.011
  
  Resource: AB_2563402
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563402
  
  What is this?
  
  RRID:AB_2563402
Visit annotations in context

Tags

RRID:AB_2563402

Annotators

scibot

URL

sciencedirect.com/science/article/abs/pii/S2405471224000322